Klothea Bio, Inc. is a biotechnology research company based in Miami, Florida, focused on advancing research and development of the Klotho protein for age-related therapeutics.
Subscribe to see Klothea Bio, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Klothea Bio, Inc. is a company headquartered in United States. Its most recent funding round raised $2.9M in October 2024. Xcout tracks 10 named people at Klothea Bio, Inc., including Agustin Fernandez Santana III (CEO).
4 more named people on record for Klothea Bio, Inc., with roles, board committees and tenure — see the full roster →
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| SEC Form D filing | $2.9M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
A few of Klothea Bio, Inc.'s closest competitors — see the full list of competitors and alternatives →
Klotho Therapeutics, Inc. is a privately held biotechnology and life sciences company headquartered in San Diego, California. Founded in 2016, the venture-backed firm specializes in the synthetic replication of the Klotho protein.
Immorta Bio, Inc. is a regenerative medicine and scientific longevity company dedicated to providing innovative health solutions. Headquartered in Miami Beach, Florida, the company develops specialized therapeutics and operates within the biotechnology sector.
AION Healthspan, Inc. is a clinical-stage biotechnology and healthspan company headquartered in Miami, Florida. The firm focuses on developing therapeutics and initiating clinical trials targeting age-related diseases and diabetic conditions.
Kaida BioPharma Inc. is a biotechnology company operating in the deep-tech therapeutic R&D sector with a corporate office located in Fort Lauderdale, Florida.
Galatea Bio, Inc. is a biotechnology research company headquartered in Miami Lakes, Florida. The company operates within the biotech industry with a team size of 11 to 50 employees.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Post the link and the card appears automatically — each network fetches the image itself.